RED CELL THERAPEUTICS - Trademark Details
Status: 700 - Registered
Serial Number
88807844
Registration Number
6532454
Word Mark
RED CELL THERAPEUTICS
Status
700 - Registered
Status Date
2021-10-19
Filing Date
2020-02-24
Registration Number
6532454
Registration Date
2021-10-19
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
FALK, JONATHAN ROBERT
Statements
Disclaimer with Predetermined Text
"CELL THERAPEUTICS"
Goods and Services
Cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; pharmaceutical preparations of engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; none of the foregoing used as vitamin-mineral supplements or for animals
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-02-27
Primary Code
005
First Use Anywhere Date
2020-11-11
First Use In Commerce Date
2020-11-11
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
CHRISTINA M. LICURSI
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-02-27 | NEW APPLICATION ENTERED IN TRAM |
2020-02-27 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-03-06 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2020-03-13 | ASSIGNED TO LIE |
2020-03-21 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
2020-05-13 | ASSIGNED TO EXAMINER |
2020-05-20 | NON-FINAL ACTION WRITTEN |
2020-05-20 | NON-FINAL ACTION E-MAILED |
2020-05-20 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-11-19 | TEAS AMENDMENT OF USE RECEIVED |
2020-11-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-11-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-11-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-11-19 | USE AMENDMENT FILED |
2021-01-12 | AMENDMENT TO USE PROCESSING COMPLETE |
2021-02-06 | USE AMENDMENT ACCEPTED |
2021-02-06 | NON-FINAL ACTION WRITTEN |
2021-02-06 | NON-FINAL ACTION E-MAILED |
2021-02-06 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-02-09 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
2021-07-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-07-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-07-21 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-09-07 | EXAMINERS AMENDMENT -WRITTEN |
2021-09-07 | EXAMINERS AMENDMENT E-MAILED |
2021-09-07 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-09-07 | EXAMINER'S AMENDMENT ENTERED |
2021-09-07 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
2021-09-15 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2021-10-19 | REGISTERED-SUPPLEMENTAL REGISTER |